Clinical trial
Prospective Post-Market Clinical Follow-Up Registry to Assess the Long-term Safety and Effectiveness for the Treatment of Severe Symptomatic Aortic Valve Stenosis Using Valvosoft Non-Invasive Ultrasound Therapy
NCT07520591 is registered in ClinicalTrials.gov with Cardiawave SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Post-Market Clinical Follow-Up Registry to Assess the Long-term Safety and Effectiveness for the Treatment of Severe Symptomatic Aortic Valve Stenosis Using Valvosoft Non-Invasive Ultrasound Therapy
- Lead sponsor
- Cardiawave SA
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 30, 2026
- Completion date
- June 30, 2028
- Enrollment
- 200 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stenosis, severe, aortic valve calcification, aortic valve disease, heart failure, ultrasound therapy